139 related articles for article (PubMed ID: 8201496)
21. [Prevalence of celiac disease serological markers in Tunisian type 1 diabetic adults].
Laadhar L; Zitouni M; Kallel-Sellami M; Masmoudi S; Bouguerra R; Chaabouni H; Ben Slama C; Makni S
Ann Biol Clin (Paris); 2006; 64(5):439-44. PubMed ID: 17040874
[TBL] [Abstract][Full Text] [Related]
22. Production of antibodies to gliadin by peripheral blood lymphocytes in children with celiac disease: the use of an enzyme-linked immunospot technique for screening and follow-up.
Hansson T; Dannaeus A; Kraaz W; Sjöberg O; Klareskog L
Pediatr Res; 1997 Apr; 41(4 Pt 1):554-9. PubMed ID: 9098859
[TBL] [Abstract][Full Text] [Related]
23. Seroconversion of reticulin autoantibodies predicts coeliac disease in insulin dependent diabetes mellitus.
Mäki M; Huupponen T; Holm K; Hällström O
Gut; 1995 Feb; 36(2):239-42. PubMed ID: 7883223
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and clinical features of celiac disease in 950 children with type 1 diabetes in France.
Poulain C; Johanet C; Delcroix C; Lévy-Marchal C; Tubiana-Rufi N
Diabetes Metab; 2007 Dec; 33(6):453-8. PubMed ID: 17964843
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of coeliac disease in diabetic children and adolescents in Sweden.
Sigurs N; Johansson C; Elfstrand PO; Viander M; Lanner A
Acta Paediatr; 1993 Sep; 82(9):748-51. PubMed ID: 8241671
[TBL] [Abstract][Full Text] [Related]
26. [Anti-endomysium, anti-reticulin and anti-gliadin antibodies in the diagnosis of coeliac disease in adults].
Ghedira I; Sghiri R; Yacoubi MT; Korbi S; Jeddi M
Ann Biol Clin (Paris); 1999; 57(6):717-9. PubMed ID: 10572222
[No Abstract] [Full Text] [Related]
27. Antibodies to endomysium and gliadin in coeliac disease.
Hill PG; Holmes GK
Ann Clin Biochem; 1998 Nov; 35 ( Pt 6)():783-4. PubMed ID: 9838994
[No Abstract] [Full Text] [Related]
28. Interpretation of serological tests in the diagnosis of celiac disease: Anti-deamidated gliadin peptide antibodies revisited.
Zucchini L; Giusti D; Gatouillat G; Servettaz A; Tabary T; Barbe C; Pham BN
Autoimmunity; 2016 Sep; 49(6):414-420. PubMed ID: 27452003
[TBL] [Abstract][Full Text] [Related]
29. Gliadin antibodies in coeliac disease.
Volta U; Lenzi M; Cassani F; Lazzari R; Bianchi FB; Pisi E
Lancet; 1983 Jun; 1(8336):1285. PubMed ID: 6134084
[No Abstract] [Full Text] [Related]
30. [Antiendomysial antibodies: current role in the diagnosis of celiac disease compared to antigliadin antibodies].
Gemme G; Delogu A; Nobili F; Galeazzi G; Mariani P; Triglione P; Bonamico M
Pediatr Med Chir; 1993; 15(6):595-7. PubMed ID: 8197021
[TBL] [Abstract][Full Text] [Related]
31. [Prognostic factors of celiac disease occurrence in type 1 diabetes mellitus children].
Myśliwiec M; Balcerska A; Stepiński J; Bakowska A; Jedrzejczyk A; Bautembach-Minkowska J; Sztangierska B; Banach P; Wiśniewski P
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(4):281-5. PubMed ID: 17239306
[TBL] [Abstract][Full Text] [Related]
32. Celiac disease in insulin-dependent diabetes mellitus.
Savilahti E; Simell O; Koskimies S; Rilva A; Akerblom HK
J Pediatr; 1986 May; 108(5 Pt 1):690-3. PubMed ID: 3701514
[TBL] [Abstract][Full Text] [Related]
33. Comparison of IgA-class reticulin and endomysium antibodies in coeliac disease and dermatitis herpetiformis.
Hällström O
Gut; 1989 Sep; 30(9):1225-32. PubMed ID: 2806989
[TBL] [Abstract][Full Text] [Related]
34. [Antigliadin, antiendomysial and antireticulin antibodies in celiac disease].
Torregrosa R; Calabuig M; Polo P
An Esp Pediatr; 1990 Apr; 32(4):377. PubMed ID: 2369007
[No Abstract] [Full Text] [Related]
35. Prevalence and characteristics of coeliac disease in type 1 diabetes mellitus.
Cacciari E; Salardi S; Volta U; Biasco G; Partesotti S; Mantovani A; Cicognani A; Tonioli S; Tassoni P; Pirazzoli P
Acta Paediatr Scand; 1987 Jul; 76(4):671-2. PubMed ID: 3630686
[No Abstract] [Full Text] [Related]
36. Are immunoglobulin A anti-gliadin antibodies helpful in diagnosing coeliac disease in children younger than 2 years?
Foucher B; Johanet C; Jégo-Desplat S; Sanmarco M; Dubucquoi S; Fily-Nalewajk S; Olsson NO; Lakomy D; Escande A; Chrétien P; Fortenfant F; Chevailler A; André C; Goetz J; Humbel RL; Monier JC; Sibilia J; Taillefer MF; Abreu I; Fabien N
J Pediatr Gastroenterol Nutr; 2012 Jan; 54(1):110-2. PubMed ID: 21857243
[TBL] [Abstract][Full Text] [Related]
37. [Circulating antigliadin antibodies. Prevalence in a diabetic (type 1 or 2) and non diabetic adult population].
Tourniaire J; Guichard-Rode S; Monier JC
Presse Med; 1995 Oct; 24(31):1425-7. PubMed ID: 8545330
[TBL] [Abstract][Full Text] [Related]
38. [Antiendomysium antibodies and antigliadin antibodies in diagnosis and follow-up of celiac disease].
Cataldo F; Trippiedi MA; Marino V; Maltese I; Traverso G; Paternostro D; Albeggiani A
Minerva Pediatr; 1993; 45(1-2):29-33. PubMed ID: 8316160
[TBL] [Abstract][Full Text] [Related]
39. Celiac disease and immunoglobulin a deficiency: how effective are the serological methods of diagnosis?
Kumar V; Jarzabek-Chorzelska M; Sulej J; Karnewska K; Farrell T; Jablonska S
Clin Diagn Lab Immunol; 2002 Nov; 9(6):1295-300. PubMed ID: 12414763
[TBL] [Abstract][Full Text] [Related]
40. Immunological diagnosis of childhood coeliac disease: comparison between antigliadin, antireticulin and antiendomysial antibodies.
Lerner A; Kumar V; Iancu TC
Clin Exp Immunol; 1994 Jan; 95(1):78-82. PubMed ID: 8287612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
